Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

KGEI vs VET: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

VET Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 5–5 Matrix Metrics)

VET Overall Winner 6-Pillar Tally: KGEI 2 – 4 VET Matrix Metrics: KGEI 5 – 5 VET

As of Nov 20, 2026, Vermilion Energy Inc. (VET) is the stronger overall head-to-head candidate over Kolibri Global Energy Inc. (KGEI) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Balance Sheet & Cash Flow, Options & Positioning). KGEI carries a Unified Composite Score of 49.0/100 (HOLD) at $4.47 (5.3x Forward P/E, 39.8% operating margin), whereas VET carries 71.1/100 (BUY) at $10.25 (17.4x Forward P/E, -0.7% operating margin).

  • Technical & Structure Timing Caution: KGEI is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 24.6); meanwhile VET is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 33.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About KGEI vs VET
KGEI NASDAQ
Kolibri Global Energy Inc. Common Stock
Crude Petroleum & Natural Gas
$4.47
-3.14% 1D
Market Cap $166.1M
TTM Revenue $75M
Forward P/E 5.3x
Beta / 30D Vol -0.73β · 64% Vol
Unified Composite Score
49.0 / 100 HOLD
Tech 45.0 Fund 50.0 Flow 50.0 Mom 55.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -2.2%), weak momentum, RSI 25
RSI-14: 24.6 · SMA20: $5.78 · SMA50: $6.26
VET NYSE Head-to-Head Winner
Vermilion Energy Inc.
Crude Petroleum & Natural Gas
$10.25
-1.06% 1D
Market Cap $1.6B
TTM Revenue $1.97B
Forward P/E 17.4x
Beta / 30D Vol -0.77β · 61% Vol
Unified Composite Score
71.1 / 100 BUY
Tech 84.0 Fund 71.0 Flow 56.0 Mom 70.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -3.7%), weak momentum, RSI 33
RSI-14: 33.5 · SMA20: $11.53 · SMA50: $12.01

6-Pillar Scorecard Institutional Category Breakdown (KGEI 2 – 4 VET)

Columns: Metric · KGEI · VET
1. Valuation Multiples KGEI
Forward P/E 5.3x 17.4x
Trailing P/E 8.6x 17.4x
PEG Ratio 0.58x 3.58x
EV / Revenue 2.2x 1.4x
2. Growth & Scale VET
Revenue Growth (YoY) +20.9% +30.4%
Earnings Growth (YoY) -0.6% -94.9%
TTM Revenue (USD) $75M $1.97B
Market Cap $166.1M $1.6B
3. Profitability & Quality KGEI
Gross Margin 84.5% 64.0%
Operating Margin 39.8% -0.7%
Net Profit Margin 25.7% -24.6%
Return on Equity (ROE) 9.1% -20.1%
4. Balance Sheet & Cash Flow VET
Cash Generation (TTM) $47M EBITDA $1.31B
Cash Flow Margin 62.4% EBITDA Mgn 66.5%
Net Cash / Leverage $6.19 Book/Sh · 9.1% ROE $1.18B Net Debt (0.59x D/E)
Dividend Yield None (0.00%) 5.20%
5. Options & Positioning VET
Options Structure Phase UNCLASSIFIED CONSOLIDATION
Current IV / %ile N/A (N/A) 46.5% (23rd %ile)
Put/Call OI Skew N/A 0.30x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat VET
OpEx & R&D Intensity 44.7% of Rev ($34M) 64.7% of Rev ($1.27B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Oil & Gas E&P Operator Oil & Gas E&P Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: KGEI (5) vs VET (5)
Institutional Metric KGEI VET Criterion Row Edge
Market Capitalization
Scale
$166.1M $1.6B Larger Scale VET
Trailing P/E Ratio
Valuation
8.6x 17.4x Lower Multiple KGEI
Forward P/E Ratio
Valuation
5.3x 17.4x Lower Multiple KGEI
Revenue Growth (YoY)
Growth
+20.9% +30.4% Higher Growth VET
Operating Margin (TTM)
Profitability
39.8% -0.7% Higher Margin KGEI
Net Profit Margin
Profitability
25.7% -24.6% Higher Margin KGEI
Return on Equity (ROE)
Capital Efficiency
9.1% -20.1% Higher ROE KGEI
52-Week Range Position
Momentum
28% ($3–$7) 35% ($8–$15) Stronger Trend VET
Beta / 30D Volatility
Risk Regime
-0.73β · 64% Vol -0.77β · 61% Vol Lower Realized Risk VET
Unified Institutional Score
Composite Signal
49.0 / 100 (HOLD) 71.1 / 100 (BUY) Higher Composite VET
Trailing 12M Revenue (USD)
Operating Scale
$75M $1.97B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
84.5% 64.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.58x PEG · 2.2x EV/Rev 3.58x PEG · 1.4x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$47M EBITDA ($6.19 Book/Sh · 9.1% ROE) $1.31B ($1.18B Net Debt (0.59x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon VET +11.45 pp
KGEI: -35.24% · VET: -23.79%
3M Horizon VET +6.91 pp
KGEI: -25.17% · VET: -18.26%
6M Horizon VET +7.09 pp
KGEI: -23.76% · VET: -16.67%
1Y Horizon KGEI +0.31 pp
KGEI: +11.6% · VET: +11.29%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on KGEI vs VET. Trailing 12-month operating profitability (KGEI 39.8% vs VET -0.7%) and valuation multiples (KGEI 5.3x vs VET 17.4x Forward P/E) are benchmarked directly in Pillar 4 below.

KGEI ADR TTM Benchmark FX-Normalized USD
TTM Revenue$75M
Gross Margin84.5%
Op. Margin39.8%
ROE / Fwd P/E9.1% · 5.3x
VET ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.97B
Gross Margin64.0%
Op. Margin-0.7%
ROE / Fwd P/E-20.1% · 17.4x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
KGEI UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact KGEI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
VET CONSOLIDATION
48d in phase · OBV NEUTRAL
Current IV 46.5%
IV Percentile 23rd %ile
Put/Call OI Skew 0.30x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact VET Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
KGEI Moat Profile High-Margin Pricing Power Moat
Oil & Gas E&P Operator
Competes within the Oil & Gas E&P value chain with $166.1M market capitalization and 39.8% operating margin.
OpEx & R&D Reinvestment 44.7% of Rev ($34M)
90D Engineering Disclosures 0 Published
VET Moat Profile Cyclical / Execution-Driven Positioning
Oil & Gas E&P Operator
Competes within the Oil & Gas E&P value chain with $1.6B market capitalization and -0.7% operating margin.
OpEx & R&D Reinvestment 64.7% of Rev ($1.27B)
90D Engineering Disclosures 0 Published

Investor FAQ KGEI vs VET Key Questions & Quantitative Answers

As of Nov 20, 2026, Vermilion Energy Inc. (VET) is the stronger overall head-to-head candidate over Kolibri Global Energy Inc. (KGEI) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Balance Sheet & Cash Flow, Options & Positioning). KGEI carries a Unified Composite Score of 49.0/100 (HOLD) at $4.47 (5.3x Forward P/E, 39.8% operating margin), whereas VET carries 71.1/100 (BUY) at $10.25 (17.4x Forward P/E, -0.7% operating margin). Technical & Structure Timing Caution: KGEI is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 24.6); meanwhile VET is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 33.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

VET leads the Growth & Scale pillar: KGEI posts +20.9% YoY revenue growth and -0.6% YoY earnings growth on $75M TTM revenue (84.5% gross margin, 39.8% operating margin), compared with VET at +30.4% YoY revenue growth and -94.9% YoY earnings growth on $1.97B TTM revenue (64.0% gross margin, -0.7% operating margin). On trailing 12-month operating scale, KGEI generates $75M in USD-normalized revenue versus $1.97B for VET. In operating R&D and SG&A reinvestment, KGEI deploys 44.7% of Rev ($34M) (0 90-day corporate R&D disclosures) versus 64.7% of Rev ($1.27B) (0 disclosures) for VET.

KGEI screens cheaper on headline valuation multiples. KGEI trades at 5.3x Forward P/E, 8.6x Trailing P/E, 0.58x PEG, and 2.2x EV/Revenue (62.4% EBITDA margin), whereas VET trades at 17.4x Forward P/E, 17.4x Trailing P/E, 3.58x PEG, and 1.4x EV/Revenue (66.5% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against KGEI (9.1% ROE) versus VET (-20.1% ROE) capital efficiency.

In options market volatility and institutional positioning, KGEI carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.73β · 64% Vol realized risk). By comparison, VET carries 46.5% implied volatility (23rd %ile, Compressed (<25th %ile)), a 0.30x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.77β · 61% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.